|Bid||45.52 x 800|
|Ask||45.57 x 900|
|Day's Range||45.47 - 45.59|
|52 Week Range||26.19 - 46.70|
|Beta (5Y Monthly)||0.66|
|PE Ratio (TTM)||68.96|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||40.11|
Buy shares of Genmab (GMAB), KnowBe4 (KNBE), UserTesting (USER), Enphase Energy (ENPH) and Gartner (IT).
Here is how Elevance Health (ELV) and Genmab AS Sponsored ADR (GMAB) have performed compared to their sector so far this year.
Company Announcement COPENHAGEN, Denmark; November 23, 2022 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) made by managerial employees and their closely associated persons. The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish tradin